Aion Therapeutic Inc News

Aion Therapeutic Engages Independent Trading Group for Market Making Services

Toronto, Ontario--(Newsfile Corp. - March 4, 2024) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") is pleased to announce that it has entered into a market making services ag

newsfileMar 5 05:50

EARLY WARNING REPORT ISSUED PURSUANT TO NI 62‐103 - ACQUISITION OF SECURITIES OF AION THERAPEUTIC INC.

Yahoo FinanceDec 20, 2023 05:54

Aion Therapeutic Announces Closing of Toppen Health Inc. Acquisition

Toronto, Ontario--(Newsfile Corp. - December 15, 2023) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") is pleased to announce that, further to its press release dated October

newsfileDec 16, 2023 07:49

Aion Therapeutic Announces Definitive Agreement to Acquire Toppen Health Inc.

Toronto, Ontario--(Newsfile Corp. - October 23, 2023) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") is pleased to announce that has entered into a definitive share purchase

newsfileOct 24, 2023 02:13

Aion Therapeutic Announces Closing of Second Tranche of Non-Brokered Private Placement Offering of Units

Toronto, Ontario--(Newsfile Corp. - October 5, 2023) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") is pleased to announce that further to its press released dated September

newsfileOct 6, 2023 11:08

Aion Therapeutic Announces Second Tranche of Non-Brokered Private Placement Offering of Units

Toronto, Ontario--(Newsfile Corp. - September 8, 2023) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") is pleased to announce that it plans to complete a second tranche of it

newsfileSep 9, 2023 07:55

Aion Therapeutic Announces Director Resignation

Aion Therapeutic Inc. (CSE: AION) announces that effective July 5, 2023, Rosy Mondin has resigned as a director of the Company.

PR NewswireJul 7, 2023 05:05

Aion Therapeutic Announces Proposed Non-Brokered Private Placement Offering of Units

TORONTO, July 4, 2023 /CNW/ - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") is pleased to announce that it plans to undertake a non-brokered private placement of up to 50,000,000 units ("Units") to raise gross proceeds of up to $500,000.00 (the "Unit Offering"). The Units will be offered at a price of $0.01, with each Unit consisting of one common share ("Share") and one half of one common share purchase warrant ("Warrant"). Each full Warrant will be exercisable to acquire one Share ("Warrant Share") for a period of eighteen months following the closing of the Unit Offering at an exercise price of $0.10 per Warrant Share.

PR NewswireJul 4, 2023 23:41

Aion Therapeutic Files Financials

Toronto, Ontario--(Newsfile Corp. - November 7, 2022) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") announces that further to its press releases of September 13, 2022, Sept

newsfileNov 8, 2022 06:30

Aion Therapeutic Provides Default Status Update

Toronto, Ontario--(Newsfile Corp. - October 25, 2022) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") announces that further to its press releases of September 13, 2022, Sept

newsfileOct 26, 2022 05:00

Aion Therapeutic Reports Delay in Filing 2022 Annual Financial Statements

Toronto, Ontario--(Newsfile Corp. - August 30, 2022) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") announced today that further to its press release on August 18, 2022, the

newsfileAug 31, 2022 05:30

Aion Therapeutic Announces Intellectual Property Sale and Management and Board Changes

Toronto, Ontario--(Newsfile Corp. - June 30, 2022) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") announced today that it has sold four patent applications and all associate

newsfileJul 1, 2022 05:10